Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ten Cate

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
Neurology|February 4, 2012
Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patientsI L H Knottnerus, K Winckers, H Ten Cate, et al.
Thrombosis Research|May 11, 2016
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational statusA Vignoli, S Tessarolo, M Marchetti, et al.
The Journal of Clinical Investigation|February 14, 1998
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factorM C Minnema, P W Friederich, M Levi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 13, 2011
Factor XII activation is essential to sustain the procoagulant effects of particulate matterE Kilinç, R Van Oerle, J I Borissoff, et al.
Thrombosis and Haemostasis|February 1, 1995
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIaB J Biemond, M Levi, H ten Cate, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
The plasma kallikrein-kinin system and risk of cardiovascular disease in menJ W P Govers-Riemslag, M Smid, J A Cooper, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuriaB K Mahmoodi, A B Mulder, F Waanders, et al.
Journal of Thrombosis and Haemostasis : JTH|November 28, 2008
Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in miceS T B G Loubele, C A Spek, P Leenders, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 1, 2021
Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse eventsR H Olie, P E J van der Meijden, M J A Vries, et al.
The Journal of Clinical Investigation|January 1, 1994
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzeesM Levi, H ten Cate, K A Bauer, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Neurology|February 4, 2012
Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patientsI L H Knottnerus, K Winckers, H Ten Cate, et al.
Thrombosis Research|May 11, 2016
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational statusA Vignoli, S Tessarolo, M Marchetti, et al.
The Journal of Clinical Investigation|February 14, 1998
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factorM C Minnema, P W Friederich, M Levi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 13, 2011
Factor XII activation is essential to sustain the procoagulant effects of particulate matterE Kilinç, R Van Oerle, J I Borissoff, et al.
Thrombosis and Haemostasis|February 1, 1995
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIaB J Biemond, M Levi, H ten Cate, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
The plasma kallikrein-kinin system and risk of cardiovascular disease in menJ W P Govers-Riemslag, M Smid, J A Cooper, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuriaB K Mahmoodi, A B Mulder, F Waanders, et al.
Journal of Thrombosis and Haemostasis : JTH|November 28, 2008
Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in miceS T B G Loubele, C A Spek, P Leenders, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 1, 2021
Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse eventsR H Olie, P E J van der Meijden, M J A Vries, et al.
The Journal of Clinical Investigation|January 1, 1994
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzeesM Levi, H ten Cate, K A Bauer, et al.
Pageof 19